CompuGroup Medical SE & Co. KGaA: Share Buy-Back Program - 2nd Interim Announcement

DGAP Post-admission Duties announcement: CompuGroup Medical SE & Co. KGaA / Share Buy-Back CompuGroup Medical SE & Co. KGaA: Share Buy-Back Program - 2nd Interim Announcement 13.12.2021 / 15:50 Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. Disclosure pursuant to Art. 5 para. 1 lit. b) and para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 para. 2 and para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 CompuGroup Medical SE & Co. KGaA: Share Buy-Back Program - 2nd Interim Announcement In the period from December 6, 2021 until and including December 10, 2021, CompuGroup Medical SE & Co. KGaA has bought back an aggregate number of 78,471 shares in CompuGroup Medical SE & Co. KGaA within its share buy-back program which had been announced on November 25, 2021 pursuant to Art. 2 para. 1 Commission Delegated Regulation (EU) No 2016/1052 to start on November 26, 2021. The aggregate number of shares bought back each day during the period from December 6, 2021 until and including December 10, 2021 as well as the daily volume-weighted average prices for such buy-backs are as follows: Date Aggregate volume (number of no-par value shares) Volume-weighted average price (in EUR, excluding ancillary costs and charges) December 6, 2021 14,073 66.0743 December 7, 2021 14,151 67.0638 December 8, 2021 16,454 67.3896 December 9, 2021 16,795 66.9662 December 10, 2021 16,998 65.8642 Total: 78,471 66.6716         The aggregate number of shares bought back within the share buy-back program in the period from November 26, 2021 until and including December 10, 2021 amounts to 156,692 shares. Detailed information about the transactions are published on the company's website under www.cgm.com/sbb. The acquisitions of the shares in CompuGroup Medical SE & Co. KGaA were carried out by a credit institution assigned by CompuGroup Medical SE & Co. KGaA exclusively via the Frankfurt Stock Exchange (XETRA trading). Koblenz, December 13, 2021 CompuGroup Medical SE & Co. KGaA The general partner 13.12.2021 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language:	English
Company:	CompuGroup Medical SE & Co. KGaA
	Maria Trost 21
	56070 Koblenz
	Germany
Internet:	www.cgm.com

End of News	DGAP News Service

1257282  13.12.2021